Back Cover: Discovery of a Highly Selective PLD2 Inhibitor (ML395): A New Probe with Improved Physiochemical Properties and Broad-Spectrum Antiviral Activity against Influenza Strains (ChemMedChem 12/2014)
Further chemical optimization of the halopemide-derived family of dual phospholipaseD1/2 (PLD1/2) inhibitors afforded ML395 (VU0468809), a potent, >80-fold PLD2 selective allosteric inhibitor (cellular PLD1, IC50 >30000nM; cellular PLD2, IC50 =360nM). Moreover, ML395 possesses an attractive in...
Saved in:
Published in | ChemMedChem Vol. 9; no. 12; p. 2820 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY-VCH Verlag
01.12.2014
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 1860-7179 1860-7187 |
DOI | 10.1002/cmdc.201490047 |
Cover
Abstract | Further chemical optimization of the halopemide-derived family of dual phospholipaseD1/2 (PLD1/2) inhibitors afforded ML395 (VU0468809), a potent, >80-fold PLD2 selective allosteric inhibitor (cellular PLD1, IC50 >30000nM; cellular PLD2, IC50 =360nM). Moreover, ML395 possesses an attractive in vitro DMPK profile, improved physiochemical properties, ancillary pharmacology (Eurofins Panel) cleaner than any other reported PLD inhibitor, and has been found to possess interesting activity as an antiviral agent in cellular assays against a range of influenza strains (H1, H3, H5 and H7). |
---|---|
AbstractList | Further chemical optimization of the halopemide-derived family of dual phospholipaseD1/2 (PLD1/2) inhibitors afforded ML395 (VU0468809), a potent, >80-fold PLD2 selective allosteric inhibitor (cellular PLD1, IC50 >30000nM; cellular PLD2, IC50 =360nM). Moreover, ML395 possesses an attractive in vitro DMPK profile, improved physiochemical properties, ancillary pharmacology (Eurofins Panel) cleaner than any other reported PLD inhibitor, and has been found to possess interesting activity as an antiviral agent in cellular assays against a range of influenza strains (H1, H3, H5 and H7). |
Author | O'Reilly, Matthew C. Locuson, Charles W. Thomas, Paul G. Oguin III, Thomas H. Scott, Sarah A. Morrison, Ryan D. Daniels, J. Scott Brown, H. Alex Lindsley, Craig W. |
Author_xml | – sequence: 1 givenname: Matthew C. surname: O'Reilly fullname: O'Reilly, Matthew C. organization: Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Specialized Chemistry Center (MLPCN), Vanderbilt University Medical Center, Nashville, TN 37232-6600 (USA) – sequence: 2 givenname: Thomas H. surname: Oguin III fullname: Oguin III, Thomas H. organization: Department of Immunology, St. Jude Children's Hospital, Memphis, TN 38105 (USA) – sequence: 3 givenname: Sarah A. surname: Scott fullname: Scott, Sarah A. organization: Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Specialized Chemistry Center (MLPCN), Vanderbilt University Medical Center, Nashville, TN 37232-6600 (USA) – sequence: 4 givenname: Paul G. surname: Thomas fullname: Thomas, Paul G. organization: Department of Immunology, St. Jude Children's Hospital, Memphis, TN 38105 (USA) – sequence: 5 givenname: Charles W. surname: Locuson fullname: Locuson, Charles W. organization: Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Specialized Chemistry Center (MLPCN), Vanderbilt University Medical Center, Nashville, TN 37232-6600 (USA) – sequence: 6 givenname: Ryan D. surname: Morrison fullname: Morrison, Ryan D. organization: Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Specialized Chemistry Center (MLPCN), Vanderbilt University Medical Center, Nashville, TN 37232-6600 (USA) – sequence: 7 givenname: J. Scott surname: Daniels fullname: Daniels, J. Scott organization: Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Specialized Chemistry Center (MLPCN), Vanderbilt University Medical Center, Nashville, TN 37232-6600 (USA) – sequence: 8 givenname: H. Alex surname: Brown fullname: Brown, H. Alex organization: Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Specialized Chemistry Center (MLPCN), Vanderbilt University Medical Center, Nashville, TN 37232-6600 (USA) – sequence: 9 givenname: Craig W. surname: Lindsley fullname: Lindsley, Craig W. email: craig.lindsley@vanderbilt.edu organization: Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt Specialized Chemistry Center (MLPCN), Vanderbilt University Medical Center, Nashville, TN 37232-6600 (USA) |
BookMark | eNo9kc1u2zAQhIUiBZqkvfa8QC_JQQ5JSaSYm-O0tgEndesWORIUtYqY6Mcl5aTuO_adSsGFT7tYfDuDwZxFJ13fYRR9pGRCCWFXpi3NhBGaSkJS8SY6pTknsaC5ODnuQr6Lzrx_CkSa0_w0-nujzTPM-hd013BrvRm3PfQVaFjYx7rZwwYbNIN9QVivbhksu9oWdugdXNytEpldXsMU7vEV1q4vEF7tUMOy3bogVMK63nvbmxpba3QzIlt0g0UPuivhxvW6jDfbIO92LUy74GJd4Kajnx32oB-17fwQTKtmh90fDZvBjSe4mAXROyzHAZRdjcEv30dvK914_PB_nkc_v3z-MVvEq6_z5Wy6ig0lGYtpwVORVRwLlCnPU8wkLyWSpEq0EUmWcllRFEUmUylFRspEV6bQJWMlzw0rkvPo00E3xPy1Qz-op37numCpKGdciIwxFqjJgTKu995hpbbOttrtFSVqrEyNlaljZeEhPjxYP-DvI63ds-IiEZl6uJ-r7DuZbx6-cbVI_gEKu5qv |
ContentType | Journal Article |
Copyright | 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim |
Copyright_xml | – notice: 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim |
DBID | BSCLL AAYXX CITATION 7QO 7TK 7U7 8FD C1K FR3 K9. P64 RC3 |
DOI | 10.1002/cmdc.201490047 |
DatabaseName | Istex CrossRef Biotechnology Research Abstracts Neurosciences Abstracts Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts |
DatabaseTitle | CrossRef Genetics Abstracts Biotechnology Research Abstracts Technology Research Database Toxicology Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management |
DatabaseTitleList | Genetics Abstracts |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1860-7187 |
EndPage | 2820 |
ExternalDocumentID | 3503483261 10_1002_cmdc_201490047 ark_67375_WNG_5R0GSWQ6_H |
GroupedDBID | --- 05W 0R~ 1L6 1OC 29B 31~ 33P 3WU 4.4 53G 5GY 66C 6J9 77Q 8-0 8-1 AAESR AAHQN AAMMB AAMNL AANHP AANLZ AASGY AAXRX AAYCA AAZKR ABCUV ABIJN ABJNI ABLJU ACAHQ ACBWZ ACCZN ACGFS ACIWK ACPOU ACPRK ACRPL ACXBN ACXQS ACYXJ ADBBV ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEGXH AEIGN AENEX AEUYR AEYWJ AFBPY AFFNX AFFPM AFGKR AFRAH AFWVQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHMBA AIDQK AIDYY AITYG AIURR ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMYDB ASPBG AVWKF AZFZN AZVAB BDRZF BFHJK BMXJE BRXPI BSCLL CS3 DCZOG DR2 DRFUL DRSTM DU5 EBD EBS EJD EMOBN F5P FEDTE G-S GODZA HBH HF~ HGLYW HHZ HVGLF HZ~ IX1 LATKE LAW LEEKS LH4 LITHE LOXES LUTES LW6 LYRES MEWTI MXFUL MXSTM MY~ O9- OIG P2W PQQKQ ROL SUPJJ SV3 W99 WBKPD WOHZO WXSBR XV2 YZZ ZZTAW ~S- AAHHS AAYXX ACCFJ ADZOD AEEZP AEQDE AIWBW AJBDE CITATION 7QO 7TK 7U7 8FD C1K FR3 K9. P64 RC3 |
ID | FETCH-LOGICAL-c1052-1b6475f6ebe94684e596d9e03f3ac735469f1e7b59499750d3afcbad22d68c2b3 |
ISSN | 1860-7179 |
IngestDate | Fri Jul 25 12:14:04 EDT 2025 Tue Jul 01 00:20:13 EDT 2025 Tue Sep 09 05:32:07 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1052-1b6475f6ebe94684e596d9e03f3ac735469f1e7b59499750d3afcbad22d68c2b3 |
Notes | istex:8C1B70ADF93B4756E02D57F131A64983AE1E3B3B ArticleID:CMDC201490047 ark:/67375/WNG-5R0GSWQ6-H ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
PQID | 1626775222 |
PQPubID | 986335 |
PageCount | 1 |
ParticipantIDs | proquest_journals_1626775222 crossref_primary_10_1002_cmdc_201490047 istex_primary_ark_67375_WNG_5R0GSWQ6_H |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-12 2014-12-00 20141201 |
PublicationDateYYYYMMDD | 2014-12-01 |
PublicationDate_xml | – month: 12 year: 2014 text: 2014-12 |
PublicationDecade | 2010 |
PublicationPlace | Weinheim |
PublicationPlace_xml | – name: Weinheim |
PublicationTitle | ChemMedChem |
PublicationTitleAlternate | ChemMedChem |
PublicationYear | 2014 |
Publisher | WILEY-VCH Verlag Wiley Subscription Services, Inc |
Publisher_xml | – name: WILEY-VCH Verlag – name: Wiley Subscription Services, Inc |
SSID | ssj0044818 |
Score | 2.0434773 |
Snippet | Further chemical optimization of the halopemide-derived family of dual phospholipaseD1/2 (PLD1/2) inhibitors afforded ML395 (VU0468809), a potent, >80-fold... |
SourceID | proquest crossref istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 2820 |
SubjectTerms | antivirals inhibitors lipids Pharmacology phospholipase D PLD2 |
Title | Back Cover: Discovery of a Highly Selective PLD2 Inhibitor (ML395): A New Probe with Improved Physiochemical Properties and Broad-Spectrum Antiviral Activity against Influenza Strains (ChemMedChem 12/2014) |
URI | https://api.istex.fr/ark:/67375/WNG-5R0GSWQ6-H/fulltext.pdf https://www.proquest.com/docview/1626775222 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYoXHqp-lShtJpDS0ElZeMkzoYbLS9VC2xhEdwi23HoinaplkUq_Mf-p87YzmNL1dcliZwoUTKfJzPjmW8YeylFGhZa6oBnRKodGREoI0yAvoYqVBJrbdt07u2L3eP4w2lyOnNnsZW1dDVRb_XNL-tK_keqOIZypSrZf5BsfVMcwGOUL25Rwrj9Kxm_k_ocZzQlYaJjvzm81HR87WoeKYPjM2oG2-iG8oP6vU2O-uDTUOEsprYa3b1elCWveObK0ynVsU_VQS4468INaI_aJFFqrOWYBfoUvh8TD6tdeEA_XhYBtbGfjCnYP6J2FFT1v6F9Ywp5JodohOKjbT-UG0lL4TRkV5DxtnumoN2bkFha0VSIq_BExaDQXNPO0Tk0Q98n2zctbyK-B2dXjhvB5T81FRhH2ieo2Eh4E8h111Wpkr7hmA-GhPFPiSV_VrktVd8VnQCdWfdCpj3mTQD_f8ja04C3lX3X1vHd_gs5Vlv9pSCOTHRBiZKz-d9WOQb7B_n2ca-XD7ZOB9NnnXmRdKIY9S359nM8RcuQTP7DmhwN_Wobva7fo6Ik7fC16UdPmVxzpD2-3bI8rDk1uM_ueT8INhyoH7AZM3rIlvqOSP16FQZNXeDlKixBv6FYv37EvhPywSJ_HWrcw0UJEhzuocY9EO6hxj0sW9SvrMMGIOLBIh4I8VAhHqYRDw3iAREP04iHGvFQIR484qFGPHjEw3ILyxDyNfp6K4_Z8fbW4P1u4BuTBBrdER6ESsRpUgpUgFksurFJMlFkphOVkdRplMQiK0OTqoSYn9AkLyJZaiULzgvR1VxFT9js6GJknjLQUhn0AtCPCYs4U1JKU6aqjHWYGB0XfJ69rmSXf3X8M7ljGuc5STmvpTzPlqxo68vk-JyyNtMkP9nfyZPDzs7RyUeR786zxUr2uVdml3kouEhTdMb4wu9PP2N3m4m3yGbxS5vnaJdP1AsLzx_9y-KN |
linkProvider | Wiley-Blackwell |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Back+Cover%3A+Discovery+of+a+Highly+Selective+PLD2+Inhibitor+%28ML395%29%3A+A+New+Probe+with+Improved+Physiochemical+Properties+and+Broad-Spectrum+Antiviral+Activity+against+Influenza+Strains+%28ChemMedChem+12%2F2014%29&rft.jtitle=ChemMedChem&rft.au=O%27Reilly%2C+Matthew+C&rft.au=Oguin%2C+Thomas+H&rft.au=Scott%2C+Sarah+A&rft.au=Thomas%2C+Paul+G&rft.date=2014-12-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1860-7179&rft.eissn=1860-7187&rft.volume=9&rft.issue=12&rft.spage=2820&rft_id=info:doi/10.1002%2Fcmdc.201490047&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=3503483261 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1860-7179&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1860-7179&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1860-7179&client=summon |